{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:35:57Z","timestamp":1789785357123,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05719-9","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T10:02:32Z","timestamp":1724061752000},"page":"4531-4539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study"],"prefix":"10.1007","volume":"183","author":[{"given":"Liulu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"5719_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ghir.2007.11.004","volume":"18","author":"JM Wit","year":"2008","unstructured":"Wit JM, Clayton PE, Rogol AD et al (2008) Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 18:89\u2013110. https:\/\/doi.org\/10.1016\/j.ghir.2007.11.004","journal-title":"Growth Horm IGF Res"},{"key":"5719_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ecl.2005.04.003","volume":"34","author":"RA Gubitosi-Klug","year":"2005","unstructured":"Gubitosi-Klug RA, Cuttler L (2005) Idiopathic short stature. Endocrinol Metab Clin North Am 34:565\u201380. https:\/\/doi.org\/10.1016\/j.ecl.2005.04.003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5719_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000184851","volume":"45","author":"MB Ranke","year":"1996","unstructured":"Ranke MB (1996) Towards a consensus on the definition of idiopathic short stature. Horm Res 45:64\u201366. https:\/\/doi.org\/10.1159\/000184851","journal-title":"Horm Res"},{"key":"5719_CR4","doi-asserted-by":"publisher","first-page":"5732694","DOI":"10.1155\/2018\/5732694","volume":"2018","author":"S Wu","year":"2018","unstructured":"Wu S, Liu Q-Q, Gu W et al (2018) A retrospective analysis of patients with short stature in the south of China between 2007 and 2015. Biomed Res Int 2018:5732694. https:\/\/doi.org\/10.1155\/2018\/5732694","journal-title":"Biomed Res Int"},{"key":"5719_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s10728-020-00390-1","volume":"28","author":"MC Murano","year":"2020","unstructured":"Murano MC (2020) A disability bioethics reading of the FDA and EMA evaluations on the marketing authorisation of growth hormone for idiopathic short stature children. Health Care Anal 28:266\u2013282. https:\/\/doi.org\/10.1007\/s10728-020-00390-1","journal-title":"Health Care Anal"},{"key":"5719_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/jcm11072034","volume":"11","author":"J Dahlgren","year":"2022","unstructured":"Dahlgren J, Noordam C (2022) Growth, endocrine features, and growth hormone treatment in noonan syndrome. J Clin Med 11:2034. https:\/\/doi.org\/10.3390\/jcm11072034","journal-title":"J Clin Med"},{"key":"5719_CR7","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2008-0509","volume":"93","author":"P Cohen","year":"2008","unstructured":"Cohen P, Rogol AD, Deal CL et al (2008) Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93:4210\u20134217. https:\/\/doi.org\/10.1210\/jc.2008-0509","journal-title":"J Clin Endocrinol Metab"},{"key":"5719_CR8","doi-asserted-by":"publisher","first-page":"864908","DOI":"10.3389\/fendo.2022.864908","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan J, Fu J, Wei H et al (2022) A randomized controlled phase 3 study on the efficacy and safety of recombinant human growth hormone in children with idiopathic short stature. Front Endocrinol (Lausanne) 13:864908. https:\/\/doi.org\/10.3389\/fendo.2022.864908","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5719_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ghir.2018.09.003","volume":"42\u201343","author":"Y-Q Ying","year":"2018","unstructured":"Ying Y-Q, Hou L, Liang Y et al (2018) Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature. Growth Horm IGF Res 42\u201343:80\u20135. https:\/\/doi.org\/10.1016\/j.ghir.2018.09.003","journal-title":"Growth Horm IGF Res"},{"key":"5719_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12887-020-02034-8","volume":"20","author":"D Wu","year":"2020","unstructured":"Wu D, Chen R-M, Chen S-K et al (2020) Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty. BMC Pediatr 20:138. https:\/\/doi.org\/10.1186\/s12887-020-02034-8","journal-title":"BMC Pediatr"},{"key":"5719_CR11","doi-asserted-by":"publisher","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JGB, Gunn AJ et al (2011) Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS ONE 6:e16223. https:\/\/doi.org\/10.1371\/journal.pone.0016223","journal-title":"PLoS ONE"},{"key":"5719_CR12","doi-asserted-by":"publisher","unstructured":"Ben-Ari T, Chodick G, Shalev V, et al (2021) Real-world treatment patterns and outcomes of growth hormone treatment among children in Israel over the past decade (2004\u20132015). Front Pediatr 9. https:\/\/doi.org\/10.3389\/fped.2021.711979","DOI":"10.3389\/fped.2021.711979"},{"key":"5719_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0905","volume":"177","author":"X Luo","year":"2017","unstructured":"Luo X, Hou L, Liang L et al (2017) Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies. Eur J Endocrinol 177:195\u2013205. https:\/\/doi.org\/10.1530\/EJE-16-0905","journal-title":"Eur J Endocrinol"},{"key":"5719_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/DDDT.S93183","volume":"10","author":"L Hou","year":"2016","unstructured":"Hou L, Chen Z-H, Liu D et al (2016) Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children. Drug Des Devel Ther 10:13\u201321. https:\/\/doi.org\/10.2147\/DDDT.S93183","journal-title":"Drug Des Devel Ther"},{"key":"5719_CR15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1210\/clinem\/dgad039","volume":"108","author":"L Hou","year":"2023","unstructured":"Hou L, Huang K, Gong C et al (2023) Long-term Pegylated GH for children with GH deficiency: a large, prospective, real-world study. J Clin Endocrinol Metab 108:2078\u20132086. https:\/\/doi.org\/10.1210\/clinem\/dgad039","journal-title":"J Clin Endocrinol Metab"},{"key":"5719_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12902-022-01101-8","volume":"22","author":"J Chen","year":"2022","unstructured":"Chen J, Zhong Y, Wei H et al (2022) Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study. BMC Endocr Disord 22:201. https:\/\/doi.org\/10.1186\/s12902-022-01101-8","journal-title":"BMC Endocr Disord"},{"key":"5719_CR17","doi-asserted-by":"publisher","unstructured":"Jiang Z, Chen X, Dong G, et al (2022) Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: a randomized, dose-comparison study. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.955809","DOI":"10.3389\/fphar.2022.955809"},{"key":"5719_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jcpt.12732","volume":"43","author":"Y Guan","year":"2018","unstructured":"Guan Y, He F, Wu J et al (2018) A long-acting pegylated recombinant human growth hormone (Jintrolong \u00ae ) in healthy adult subjects: two single-dose trials evaluating safety, tolerability and pharmacokinetics. J Clin Pharm Ther 43:640\u2013646. https:\/\/doi.org\/10.1111\/jcpt.12732","journal-title":"J Clin Pharm Ther"},{"key":"5719_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/a-1842-0724","volume":"54","author":"X Gao","year":"2022","unstructured":"Gao X, Chen J, Cao B et al (2022) First clinical study on long-acting growth hormone therapy in children with Turner syndrome. Horm Metab Res 54:389\u2013395. https:\/\/doi.org\/10.1055\/a-1842-0724","journal-title":"Horm Metab Res"},{"key":"5719_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/EJE-22-0449","volume":"187","author":"X Luo","year":"2022","unstructured":"Luo X, Zhao S, Yang Y et al (2022) Long-acting PEGylated growth hormone in children with idiopathic short stature. Eur J Endocrinol 187:709\u2013718. https:\/\/doi.org\/10.1530\/EJE-22-0449","journal-title":"Eur J Endocrinol"},{"key":"5719_CR21","first-page":"487","volume":"47","author":"H Li","year":"2019","unstructured":"Li H, Ji C-Y, Zong X-N et al (2019) Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47:487\u201392","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"5719_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000489262","volume":"90","author":"JS Hwang","year":"2018","unstructured":"Hwang JS, Lee HS, Lee K-H et al (2018) Once-weekly administration of sustained-release growth hormone in Korean prepubertal children with idiopathic short stature: a randomized, controlled phase II study. Horm Res Paediatr 90:54\u201363. https:\/\/doi.org\/10.1159\/000489262","journal-title":"Horm Res Paediatr"},{"key":"5719_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502231","volume":"92","author":"PF Collett-Solberg","year":"2019","unstructured":"Collett-Solberg PF, Ambler G, Backeljauw PF et al (2019) Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Horm Res Paediatr 92:1\u201314. https:\/\/doi.org\/10.1159\/000502231","journal-title":"Horm Res Paediatr"},{"key":"5719_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1210\/jcem.87.1.8150","volume":"87","author":"P Cohen","year":"2002","unstructured":"Cohen P, Bright GM, Rogol AD et al (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 87:90\u201398. https:\/\/doi.org\/10.1210\/jcem.87.1.8150","journal-title":"J Clin Endocrinol Metab"},{"key":"5719_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1515\/jpem-2021-0389","volume":"34","author":"A Soliman","year":"2021","unstructured":"Soliman A, Rogol AD, Elsiddig S et al (2021) Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment. J Pediatr Endocrinol Metab 34:1263\u20131271. https:\/\/doi.org\/10.1515\/jpem-2021-0389","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5719_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1534735403259152","volume":"2","author":"DB Boyd","year":"2003","unstructured":"Boyd DB (2003) Insulin and cancer. Integr Cancer Ther 2:315\u2013329. https:\/\/doi.org\/10.1177\/1534735403259152","journal-title":"Integr Cancer Ther"},{"key":"5719_CR27","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","volume":"105","author":"BS Miller","year":"2020","unstructured":"Miller BS, Velazquez E, Yuen KCJ (2020) Long-acting growth hormone preparations \u2013 current status and future considerations. J Clin Endocrinol Metab 105:e2121\u2013e2133. https:\/\/doi.org\/10.1210\/clinem\/dgz149","journal-title":"J Clin Endocrinol Metab"},{"key":"5719_CR28","doi-asserted-by":"publisher","first-page":"101532","DOI":"10.1016\/j.ghir.2023.101532","volume":"69\u201370","author":"G Sodero","year":"2023","unstructured":"Sodero G, Cipolla C, Pane LC et al (2023) Efficacy and safety of growth hormone therapy in children with Noonan syndrome. Growth Hormone & IGF Research 69\u201370:101532. https:\/\/doi.org\/10.1016\/j.ghir.2023.101532","journal-title":"Growth Hormone & IGF Research"},{"key":"5719_CR29","doi-asserted-by":"publisher","first-page":"106805","DOI":"10.1016\/j.phrs.2023.106805","volume":"193","author":"C Mameli","year":"2023","unstructured":"Mameli C, Orso M, Calcaterra V et al (2023) Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis. Pharmacol Res 193:106805. https:\/\/doi.org\/10.1016\/j.phrs.2023.106805","journal-title":"Pharmacol Res"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05719-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05719-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05719-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:10:20Z","timestamp":1726729820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05719-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5719"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05719-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the First Affiliated Hospital of Sun Yat-Sen University Institutional Review (approval number [2020]360) and conducted in accordance with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}